Yuan-Chuan Chen

Apr 29, 2024 | mdpi.com | Yujun Liu |Yuan-Chuan Chen |Fenyong Liu

All articles published by MDPI are made immediately available worldwide under an open access license. No specialpermission is required to reuse all or part of the article published by MDPI, including figures and tables. Forarticles published under an open access Creative Common CC BY license, any part of the article may be reused withoutpermission provided that the original article is clearly cited. For more information, please refer tohttps://www.mdpi.com/openaccess.

Apr 21, 2023 | mdpi.com | Yujun Liu |Yuan-Chuan Chen |Fenyong Liu

AltmetricshareShareannouncementHelpformat_quoteCitethumb_up... Endorsetextsms... CommentNeed Help? SupportFind support for a specific problem in the support section of our website. Get SupportFeedbackPlease let us know what you think of our products and services. Give FeedbackInformationVisit our dedicated information section to learn more about MDPI.

Apr 9, 2023 | mdpi.com | Yujun Liu |Yuan-Chuan Chen |Fenyong Liu |Isadora Zhang

Abstract: Simple SummaryAcquired immunodeficiency syndrome (AIDS), which is caused by human immunodeficiency virus (HIV), is a significant global public health concern. It is critical to generate new compounds and explore novel strategies against HIV infection to eliminate HIV-associated diseases such as AIDS. RNA enzymes, or ribozymes, represent a novel class of gene-targeting molecules with promising therapeutic potentials for the treatment of human diseases.

Mar 3, 2023 | mdpi.com | Yujun Liu |Yuan-Chuan Chen |Fenyong Liu

Open AccessArticlebyBin Yan 1,†, Yujun Liu 1,†, Yuan-Chuan Chen 2 and Fenyong Liu 1,2,* 1School of Public Health, University of California, Berkeley, CA 94720, USA2Program in Comparative Biochemistry, University of California, Berkeley, CA 94720, USA*Author to whom correspondence should be addressed. †These authors contribute equally to this study.